GILEAD SCIENCES, INC. is 89.4x more valuable than IOVANCE BIOTHERAPEUTICS, INC. by market capitalization ($151.05 B vs $1.69 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IOVA | GILD |
|---|---|---|
| Market cap | $1.69 B | $151.05 B |
| US-listed rank | #2235 | #99 |
| Revenue (latest FY) | $263.50M | $29.44B |
| Net income (latest FY) | -$391.00M | $8.51B |
| Net margin | -148.4% | 28.9% |
| P/E (trailing FY) | - | 17.7 |
| SEC filings | 1,005 | 981 |
GILEAD SCIENCES, INC. is 89.4x more valuable than IOVANCE BIOTHERAPEUTICS, INC. by market capitalization ($151.05 B vs $1.69 B).
In their latest fiscal years, IOVANCE BIOTHERAPEUTICS, INC. reported $263.50M in revenue while GILEAD SCIENCES, INC. reported $29.44B.
Full pages: IOVANCE BIOTHERAPEUTICS, INC. and GILEAD SCIENCES, INC., or browse the full rankings.